Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
We are committed to the relentless pursuit of science that can improve the lives of patients.
Our unique expertise in medicinal chemistry and biology has enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across Oncology and Inflammation & AutoImmunity.
Headquartered in Wilmington, Delaware, Incyte has more than 1,700 employees and operations in North America, Europe and Asia.
We are proud to have been recently recognized by Forbes as one of the World’s Most Innovative Companies. Additionally, Incyte has consecutively been named a Top Employer by Science Magazine, placing #2 on the 2020 list.
For more information about Incyte, please visit our corporate website at www.incyte.com and follow us on Twitter: www.twitter.com/incyte. See our Community Guidelines: http://bit.ly/2sV0H5W.
oncology, immunooncology, targeted therapy, immunology, inflammation
CSC Corporate Domains, Microsoft Office 365, Microsoft Azure Hosting, Drupal, Adobe Marketing Cloud, OneTrust, DotNetNuke, Google Font API, Google Analytics, Twitter Advertising, reCAPTCHA, Google Tag Manager, Facebook Login (Connect), Facebook Widget, Facebook Custom Audiences, Workday Recruit, Linkedin Marketing Solutions, New Relic, Mobile Friendly, Bootstrap Framework